Edition:
India

Biocartis Group NV (BCART.BR)

BCART.BR on Brussels Stock Exchange

12.20EUR
21 Jun 2018
Change (% chg)

€-0.30 (-2.40%)
Prev Close
€12.50
Open
€12.48
Day's High
€12.50
Day's Low
€12.16
Volume
33,944
Avg. Vol
69,269
52-wk High
€15.00
52-wk Low
€9.51

Chart for

About

Biocartis Group NV is a Belgium-based company, which specializes in the development of molecular diagnostic systems, especially for the treatment of cancers and infectious diseases, the products ensure the analysis of biomolecules associated with risk factors, early detection, treatment selection and monitoring of disease. The... (more)

Overall

Beta: --
Market Cap(Mil.): €473.27
Shares Outstanding(Mil.): 44.65
Dividend: --
Yield (%): --

Financials

BRIEF-Biocartis FY Total Operating Income Up At 23.1 Million Euros

* FY TOTAL OPERATING INCOME: EQUALED EUR 23.1M IN 2017 COMPARED TO EUR 13.8M IN 2016,

01 Mar 2018

BRIEF-The EU Provides Biocartis With Up To 24 Million Euros Debt For Infectious Disease Projects

* REG-BIOCARTIS GROUP NV: EUROPEAN UNION PROVIDES BIOCARTIS WITH UP TO EUR 24M DEBT FINANCING FACILITY FOR INFECTIOUS DISEASE PROJECTS

01 Mar 2018

BRIEF-Biocartis And Amgen Sign New Agreement

* REG-BIOCARTIS GROUP NV: BIOCARTIS AND AMGEN SIGN NEW COMPANION DIAGNOSTIC AGREEMENT FOR NOVEL ONCOLOGY COMPOUND

09 Jan 2018

Earnings vs. Estimates